Title : RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma.

Pub. Date : 2018

PMID : 30588188






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma. pirarubicin cyclin-dependent kinase inhibitor 1A (P21) Mus musculus
2 Here we found that RIPK1 and p21 may participate in the resistance to pirarubicin. pirarubicin cyclin-dependent kinase inhibitor 1A (P21) Mus musculus
3 Moreover, phosphorylation of AKT reversed the anti-proliferative effect of RIPK1 inhibitor in HCC, which proved that RIPK1-AKT-P21-dependent pathway played a key role in pirarubicin resistance. pirarubicin cyclin-dependent kinase inhibitor 1A (P21) Mus musculus
4 Upon exposure to pirarubicin treatment, xenografts under RIPK1 inhibition maintained higher levels of p21 than control xenografts. pirarubicin cyclin-dependent kinase inhibitor 1A (P21) Mus musculus